{
  "zip": "V5A 4W2",
  "sector": "",
  "longBusinessSummary": "Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics, primarily antibody-drug conjugates. Its proprietary technology targets delivery of anti-cancer drugs to cancerous tumors. The company is headquartered in Burnaby, Canada.",
  "city": "Burnaby",
  "state": "BC",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.advancedproteome.com",
  "maxAge": 1,
  "address1": "8337 Eastlake Drive",
  "industry": "",
  "address2": "Suite 104",
  "previousClose": 0.11463,
  "regularMarketOpen": 0.113,
  "twoHundredDayAverage": 0.0994964,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.113,
  "navPrice": null,
  "averageDailyVolume10Day": 250,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.11463,
  "fiftyDayAverage": 0.10666667,
  "trailingAnnualDividendRate": null,
  "open": 0.113,
  "averageVolume10days": 250,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.227062,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.113,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 360,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 19557248,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 1087,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.113,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 360,
  "fiftyTwoWeekHigh": 0.12,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.04,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.113,
  "exchange": "PNK",
  "shortName": "ADVANCED PROTEOME THERAPEUTICS ",
  "longName": "Advanced Proteome Therapeutics Corporation",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "APTCF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_30968071",
  "uuid": "c5ebbbb9-429a-3787-aafc-3a44774607ca",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -3.597,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 16675200,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.001,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1596153600,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -775064,
  "trailingEps": -0.028,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 112.99999,
  "heldPercentInsiders": 0.08123,
  "nextFiscalYearEnd": 1659225600,
  "mostRecentQuarter": 1604102400,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 28209631,
  "enterpriseValue": 1987267,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1557273600,
  "lastSplitFactor": "1:10",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.113,
  "logo_url": "https://logo.clearbit.com/advancedproteome.com"
}